Bone marrow transplantation for MHC class I deficiency corrects T-cell immunity but dissociates natural killer cell repertoire formation from function - 18/04/17
Doi : 10.1016/j.jaci.2016.06.029
Yifang Gao, PhD a, Peter D. Arkwright, FRCPCH, DPhil b, Rachel Carter, MSc a, Angelica Cazaly, PhD a, Rebecca J. Harrison, BSc a, Alexandra Mant, PhD a, Andrew J. Cant, FRCP, FRCPCH, MD c, Stephan Gadola, FRCP, PhD d, Tim J. Elliott, PhD a, Salim I. Khakoo, FRCP, MD d 
, Anthony P. Williams, MRCP, FRCPath, PhD a
, Anthony P. Williams, MRCP, FRCPath, PhD a a Academic Unit of Cancer Sciences, Faculty of Medicine, University of Southampton National Institute for Health Research Experimental Cancer Medicine Centre, Southampton, United Kingdom
b Department of Immunology, University of Manchester, Manchester Royal Infirmary, Manchester, United Kingdom
c Children's Bone Marrow Transplant Unit, Newcastle General Hospital, Newcastle upon Tyne, United Kingdom
d Academic Unit of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
© 2016
The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 138 - N° 6
P. 1733 - décembre 2016 Retour au numéro
Article précédent
- The use of asthma controller medications during pregnancy and the risk of gestational diabetes
- Véronique Baribeau, Marie-France Beauchesne, Évelyne Rey, Amélie Forget, Lucie Blais
- Air pollutant–mediated disruption of sinonasal epithelial cell barrier function is reversed by activation of the Nrf2 pathway
- Nyall R. London, Anuj Tharakan, Ana M. Rule, Andrew P. Lane, Shyam Biswal, Murugappan Ramanathan
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?